a topical treatment for acne vulgaris in patients aged 12 years and older. As part of the agreement inked in September 2023, Glenmark in-licensed the product from Cosmo Pharmaceuticals for ...

Monday said that Glenmark had received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi in the United Kingdom. Winlevi is the first topical acne ...

Cosmo will be the exclusive supplier of the product ... unmet medical need in treating acne," remarked Glenn Saldanha, Chairman & Managing Director Glenmark Pharmaceuticals Ltd.

In a joint statement, the companies said they have received approval for Winlevi, a topical treatment for acne vulgaris in patients aged 12 years and older. PTI Last Updated : 10 February 2025, 09 ...